David Arterburn to Cardiovascular Diseases
This is a "connection" page, showing publications David Arterburn has written about Cardiovascular Diseases.
Connection Strength
1.136
-
Long-term Microvascular Disease Outcomes in Patients With Type 2 Diabetes After Bariatric Surgery: Evidence for the Legacy Effect of Surgery. Diabetes Care. 2016 Aug; 39(8):1400-7.
Score: 0.359
-
Change in predicted 10-year cardiovascular risk following laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg. 2009 Feb; 19(2):184-189.
Score: 0.209
-
Comparison of Ambulatory Health Care Costs and Use Associated With Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy. JAMA Netw Open. 2022 05 02; 5(5):e229661.
Score: 0.135
-
Comparative effectiveness of gastric bypass and sleeve gastrectomy on predicted 10-year risk of cardiovascular disease 5 years after surgery. Surg Obes Relat Dis. 2022 06; 18(6):716-726.
Score: 0.134
-
Protocol for a randomized controlled trial of sitting reduction to improve cardiometabolic health in older adults. Contemp Clin Trials. 2021 12; 111:106593.
Score: 0.130
-
Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications. Diabetes Care. 2016 Jun; 39(6):912-23.
Score: 0.090
-
Bariatric surgery for obesity and metabolic conditions in adults. BMJ. 2014 Aug 27; 349:g3961.
Score: 0.079